Mineralys director Brian Taylor Slingsby sells 104,320 shares for $3 million
MLYS•Mineralys Therapeutics director Brian Taylor Slingsby disclosed selling 104,320 common shares on Sept. 22, 2026, at $28.8085 per share. His indirect holdings stood at 7,805,718 shares afterward.
1. Share sale
Slingsby disclosed the sale of 104,320 Mineralys common shares on Sept. 22, 2026, at $28.8085 per share. His indirect holdings totaled 7,805,718 shares following the transaction.




